CD274 and diffuse large B-cell lymphoma: Elevated soluble plasma PD-L1 (sPD-L1) levels in DLBCL patients has also been shown to correlate with the lowest three-year overall survival rates (3-year OS of 76% versus 89%, P<0.001) [71, 72].